Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debasis Dash

Showing results (91-100 of 94) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 94 results.
Pharmacogenomics|June 18, 2021
Pharmacogenomic landscape of COVID-19 therapies from Indian population genomesS Sahana, Ambily Sivadas, Mohit Mangla, et al.
Science (New York, N.Y.)|October 14, 2021
Genomic characterization and epidemiology of an emerging SARS-CoV-2 variant in Delhi, IndiaMahesh S Dhar, Robin Marwal, Radhakrishnan Vs, et al.
Computers in Biology and Medicine|April 28, 2022
A machine learning-based approach to determine infection status in recipients of BBV152 (Covaxin) whole-virion inactivated SARS-CoV-2 vaccine for serological surveysPrateek Singh, Rajat Ujjainiya, Satyartha Prakash, et al.
Elife|April 20, 2021
Insights from a Pan India Sero-Epidemiological survey (Phenome-India Cohort) for SARS-CoV2Salwa Naushin, Viren Sardana, Rajat Ujjainiya, et al.
Pageof 10

Showing results (91-100 of 94) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 94 results.
Pharmacogenomics|June 18, 2021
Pharmacogenomic landscape of COVID-19 therapies from Indian population genomesS Sahana, Ambily Sivadas, Mohit Mangla, et al.
Science (New York, N.Y.)|October 14, 2021
Genomic characterization and epidemiology of an emerging SARS-CoV-2 variant in Delhi, IndiaMahesh S Dhar, Robin Marwal, Radhakrishnan Vs, et al.
Computers in Biology and Medicine|April 28, 2022
A machine learning-based approach to determine infection status in recipients of BBV152 (Covaxin) whole-virion inactivated SARS-CoV-2 vaccine for serological surveysPrateek Singh, Rajat Ujjainiya, Satyartha Prakash, et al.
Elife|April 20, 2021
Insights from a Pan India Sero-Epidemiological survey (Phenome-India Cohort) for SARS-CoV2Salwa Naushin, Viren Sardana, Rajat Ujjainiya, et al.
Pageof 10